RTP-801 in Cigarette Smoke-Emphysema
RTP-801在香烟烟雾-肺气肿中的应用
基本信息
- 批准号:8396393
- 负责人:
- 金额:$ 31.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-15 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAddressAdenovirusesAirAlveolarAlveolar CellAntioxidantsApoptosisBrainBronchoalveolar LavageCardiovascular DiseasesCell DeathCellsCellular StressCellular Stress ResponseChronic Obstructive Airway DiseaseCigarette smoke-induced emphysemaComplexDataDiseaseErythroidFibroblastsFigs - dietaryGene ExpressionGene ProteinsGenesGrowth FactorHumanHypoxia Inducible FactorImmunofluorescence ImmunologicImmunohistochemistryIn VitroInflammationInflammatoryInjuryInterventionKnock-outKnockout MiceKnowledgeLeftLungLung InflammationLung diseasesMaintenanceManuscriptsMediatingMediator of activation proteinMedicineMolecularMorbidity - disease rateMusMuscleNF-kappa BNatural ImmunityNatureNuclearOxidative StressOxygenPaperPathogenesisPatientsPhysiologicalProcessProto-Oncogene Proteins c-aktPulmonary EmphysemaRoleSignal PathwaySignal TransductionSirolimusSmall Interfering RNAStressTransduction GeneTransgenic MiceTuberous sclerosis protein complexUp-RegulationVirusWorkacquired immunitybiological adaptation to stresscell growthcell injurycigarette smoke-inducedcigarette smokingdesigndynein light chainhuman FRAP1 proteinin vivoinsightlung injurymTOR proteinmortalitynovelpollutantprogramspublic health relevanceresponsescreeningsensorsmall hairpin RNAtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Our work over the past 10 years has uncovered that the disruption of alveolar structural and molecular maintenance program by cigarette smoke contributes to the pathogenesis of emphysema. The present application is centered on the concept that environmental stresses, such as caused by cigarette smoke (CS) and pollutants activate "rheostat" molecules that govern harmful alveolar septal cell responses involving oxidative stress, apoptosis, and alveolar inflammation. In line with this overall paradigm, we propose mechanistic studies targeting the cellular stress response gene RTP801, which was discovered in a screening of genes upregulated by hypoxia inducible factor-1a (HIF-a) and shown to induce oxidative stress and apoptosis. RTP801 inactivates mTORC1 (for mammalian target for rapamycin complex 1), which controls a central cell signaling pathway that acts as a physiological molecular sensor of environmental stresses. mTORC therefore integrates growth factor signaling, cell growth, and survival adaptation to adverse environmental conditions. We hypothesize that oxidative stress caused by CS activates RTP801 expression, which suppresses mTOR signaling in alveolar cells, leading to alveolar cell inflammation and apoptosis. Upregulation of RTP801 causes oxidative stress-triggered release of dynein-light chain molecule 8 (LC8) from I?B and NF-?B-activation. Our preliminary data demonstrate that RTP801 knockout mice are protected against lung inflammation, apoptosis, and emphysema caused by cigarette smoke. Specific Aim 1 will demonstrate that the stress response gene RTP801 is required for cigarette smoke- induced emphysema in mice. Specific Aim 2 will demonstrate that RTP801-induced lung inflammation and apoptosis by cigarette smoke are mediated by suppression of its downstream target mTOR. Specific Aim3 will demonstrate that RTP801 suppression of mTOR signaling causes oxidative stress-dependent displacement of the dynein-light chain molecule 8 (LC8) from I?B, leading to activation of NF-?B. These aims rely on a translational and comprehensive approach that includes knockout and transgenic mice, in vivo and in vitro manipulation of RTP801/mTOR/AKT gene expression and signaling with adenoassociated virus or adenovirus gene transduction, and siRNA or short hairpin RNA, complementary pharmacological interventions aimed at mTOR and oxidative stress, and detailed morphometric and cellular assessments of alveolar injury. Our proposal advances the concept that CS-mediated lung injury in emphysema is controlled by alveolar septal cells, as the result of the interaction of oxidative stress and molecular switches involved in cell stress responses. This interaction mediated by RTP801 may constitute a critical modulator of innate and acquired immunity and of cellular protection by growth factors, which are central to the pathogenesis of emphysema.
描述(由申请人提供):我们在过去10年的工作中发现,香烟烟雾对肺泡结构和分子维持程序的破坏有助于肺气肿的发病机制。本申请集中于这样的概念,即诸如由香烟烟雾(CS)和污染物引起的环境应激激活“变阻器”分子,所述“变阻器”分子控制涉及氧化应激、细胞凋亡和肺泡炎症的有害肺泡间隔细胞应答。根据这一总体范式,我们提出了针对细胞应激反应基因RTP 801的机制研究,RTP 801是在筛选缺氧诱导因子-1a(HIF-a)上调的基因中发现的,并显示出诱导氧化应激和细胞凋亡。RTP 801使mTORC 1(哺乳动物雷帕霉素复合物1的靶点)失活,mTORC 1控制作为环境应激的生理分子传感器的中央细胞信号传导途径。因此,mTORC整合了生长因子信号传导、细胞生长和对不利环境条件的生存适应。我们推测CS引起的氧化应激激活了RTP 801的表达,从而抑制了肺泡细胞中的mTOR信号,导致肺泡细胞炎症和凋亡。RTP 801的上调导致氧化应激触发释放动力蛋白轻链分子8(LC 8)从I?B和NF-?B激活。我们的初步数据表明,RTP 801基因敲除小鼠对香烟烟雾引起的肺部炎症,细胞凋亡和肺气肿有保护作用。具体目标1将证明应激反应基因RTP 801是香烟烟雾诱导的小鼠肺气肿所必需的。具体目标2将证明香烟烟雾引起的RTP 801诱导的肺部炎症和凋亡是通过抑制其下游靶点mTOR介导的。特异性Aim 3将证明RTP 801抑制mTOR信号传导导致动力蛋白轻链分子8(LC 8)从I?B,导致NF-?B。这些目标依赖于翻译和全面的方法,包括敲除和转基因小鼠,在体内和体外操纵RTP 801/mTOR/AKT基因表达和信号转导与腺相关病毒或腺病毒基因转导,siRNA或短发夹RNA,互补的药理学干预,旨在mTOR和氧化应激,肺泡损伤的详细形态和细胞评估。我们的建议提出的概念,CS介导的肺气肿肺损伤是由肺泡隔细胞控制,作为氧化应激和参与细胞应激反应的分子开关的相互作用的结果。这种由RTP 801介导的相互作用可能构成先天性和获得性免疫以及生长因子的细胞保护的关键调节剂,这是肺气肿发病机制的核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rubin M. Tuder其他文献
A 48-Year-Old Woman With Peripheral Neuropathy, Hypercalcemia, and Pulmonary Infiltrates
- DOI:
10.1378/chest.114.4.1205 - 发表时间:
1998-10-01 - 期刊:
- 影响因子:
- 作者:
Thomas J. Donnelly;Rubin M. Tuder;Thomas R. Vendegna - 通讯作者:
Thomas R. Vendegna
Diagnostic and therapeutic applications of bacteriophage and adeno-associated virus technologies in pulmonary emphysema
- DOI:
10.1016/j.nano.2006.10.082 - 发表时间:
2006-12-01 - 期刊:
- 影响因子:
- 作者:
I. Petrache;W. Arap;R. Pasqualini;T. Flotte;Rubin M. Tuder - 通讯作者:
Rubin M. Tuder
Kolorado Üniversitesi Tip Fakültesi, Tip Bölümü, Translasyonel Akciğer Araştirma Programi, Aurora, Kolorado, ABD;
Kolorado Üniversitesi Tip Fakültesi、Tip Bölümü、Translasyonel Akciğer Araştirma Programi、Aurora、Kolorado、ABD;
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Rubin M. Tuder;Stephen L. Archer;Peter Dorfmüller;Serpil C. Erzurum;Christophe Guignabert;Evangelos D. Michelakis;Marlene Rabinovitch;Ralph T. Schermuly;Kurt R. Stenmark;NW Morrell - 通讯作者:
NW Morrell
Pulmonary Eosinophilia Following Lung Transplantation for Sarcoidosis in Two Patients
- DOI:
10.1378/chest.123.2.629 - 发表时间:
2003-02-01 - 期刊:
- 影响因子:
- 作者:
Susan G. Gerhardt;Rubin M. Tuder;Reda E. Girgis;Stephen C. Yang;John V. Conte;Jonathan B. Orens - 通讯作者:
Jonathan B. Orens
Hypoxia and chronic lung disease
- DOI:
10.1007/s00109-007-0280-4 - 发表时间:
2007-11-27 - 期刊:
- 影响因子:4.200
- 作者:
Rubin M. Tuder;Jeong H. Yun;Anil Bhunia;Iwona Fijalkowska - 通讯作者:
Iwona Fijalkowska
Rubin M. Tuder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rubin M. Tuder', 18)}}的其他基金
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
肺动脉高压细胞与血管基质之间的动态互易性评估
- 批准号:
10224333 - 财政年份:2020
- 资助金额:
$ 31.2万 - 项目类别:
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
肺动脉高压细胞与血管基质之间的动态互易性评估
- 批准号:
10470738 - 财政年份:2020
- 资助金额:
$ 31.2万 - 项目类别:
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
肺动脉高压细胞与血管基质之间的动态互易性评估
- 批准号:
10686936 - 财政年份:2020
- 资助金额:
$ 31.2万 - 项目类别:
54th Annual Thomas L. Petty Aspen Lung Conference: COPD and Lung Cancer: Common P
第 54 届 Thomas L. Petty Aspen 肺病年度会议:慢性阻塞性肺病和肺癌:常见 P
- 批准号:
8129411 - 财政年份:2011
- 资助金额:
$ 31.2万 - 项目类别:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
COPD 和肺癌中前列环素-PPARy 轴的共同靶向
- 批准号:
8676740 - 财政年份:2011
- 资助金额:
$ 31.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.2万 - 项目类别:
Research Grant